⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Schedules of Nab-Paclitaxel in Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Schedules of Nab-Paclitaxel in Metastatic Breast Cancer

Official Title: A Randomized Phase II Study Evaluating Different Schedules of Nab-Paclitaxel in Metastatic Breast Cancer (SNAP Trial)

Study ID: NCT01746225

Interventions

nab-Paclitaxel

Study Description

Brief Summary: Longer first line chemotherapy duration has recently been associated with a modest, but significant improvement in overall survival and a clinically meaningful and statistically significant improvement in progression-free survival, in metastatic breast cancer patients. Prolonging chemotherapy until disease progression, however, must be weighed against the detrimental effects of continuous chemotherapy delivery. The SNAP trial seeks to improve the tolerability of prolonged chemotherapy administration strategy by studying alternative treatment schedules, while preserving and possibly improving treatment efficacy in this disease setting. The availability of a new nanoparticle albumin-bound taxane, nab-Paclitaxel (Abraxane®), represents an opportunity to test this hypothesis. Nab-Paclitaxel has been developed in an attempt to reduce the toxicity associated with standard taxane administration (caused by the use of chemical solvents) while increasing antitumor efficacy. The SNAP randomized phase II trial evaluates three schedules of nab-Paclitaxel as prolonged chemotherapy administration strategy. Each of three arms will be compared to a historical reference of seven-month median progression-free survival (PFS) based on the most recent trial with docetaxel as control arm to determine whether any of the three arms are worthy of further investigation.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

CHR de la Citadelle, Oncology-Haematology Unit, Liège, , Belgium

CHU Sart Tilman, Medical Oncology, Liège, , Belgium

Centre Hospitalier Peltzer-La Tourelle, Department of Clinical Cancerology, Verviers, , Belgium

Bon Secours, Cork, , Ireland

Cork University Hospital, Cork, , Ireland

Beaumont Hospital, Dublin, , Ireland

Mater Misericordiae University Hospital, Dublin, , Ireland

Mater Private Hospital, Dublin, , Ireland

St James's Hospital, Dublin, , Ireland

St Vincent's University Hospital, Dublin, , Ireland

University Hospital Galway, Galway, , Ireland

Mid-Western Regional Hospital, Limerick, , Ireland

Waterford Regional Hospital, Waterford, , Ireland

Azienda Ospedaliera SS Antonio e Biagio, Alessandria, , Italy

Ospedale degli Infermi, Biella, , Italy

IRCCS MultiMedica, Castellanza, , Italy

E.O. Ospedali Galliera, Genova, , Italy

Istituto Europeo di Oncologia (IEO), Milano, , Italy

Uo Medicina Ocologica Ospedale Di Carpri e Mirandola, Azienda USL di Modena, Modena, , Italy

Fondazione Salvatore Maugeri, Pavia, , Italy

U.O. Oncologia, AUSL Rimini, Rimini, , Italy

Universita degli Studi di Roma La Sapienza, Roma, , Italy

Azienda Osp. Universitaria di Udine, Udine, , Italy

Ospedale di Circolo e Fondatione Macchi, Varese, , Italy

Institute of Oncology, Ljubljana, , Slovenia

Hospital Universitari Vall D'Hebron, Barcelona, , Spain

Consorcop Hospitalario Provincial De Castellon, Castelló, , Spain

Hospital Universitari Arnau De Vilanova De Lleida, Lleida, , Spain

Hospital Universitari Sant Joan De Reus, Tarragona, , Spain

Hospital Universitario Lozano Blesa De Zaragoza, Zaragoza, , Spain

Kantonsspital Aarau, Aarau, , Switzerland

Universitätsspital Basel, Basel, , Switzerland

Instituto Oncologico della Svizzera Italiana, Bellinzona, , Switzerland

Universitätsspital/ Inselspital Bern, Bern, , Switzerland

Spitalzentrum Biel, Biel, , Switzerland

Kantonsspital Graubünden, Chur, , Switzerland

Kantonsspital Baselland, Liestal, , Switzerland

Luzerner Kantonsspital, Luzern, , Switzerland

Kantonsspital St. Gallen, St. Gallen, , Switzerland

Onkologiezentrum Thun-Berner Oberland, Thun, , Switzerland

Kantonsspital Winterthur, Winterthur, , Switzerland

Contact Details

Name: Alessandra Gennari, MD

Affiliation: Division of Medical Oncology, E.O. Galliera, Genoa, Italy

Role: STUDY_CHAIR

Name: Guy Jerusalem, MD, PhD

Affiliation: CHU Sart Tilman and University of Liège, Liège, Belgium

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: